Beautiful Virgin Islands

Thursday, Oct 30, 2025

UK recognition of EU’s vaccine effort would not go amiss, says Brussels

UK recognition of EU’s vaccine effort would not go amiss, says Brussels

Europe could have fully vaccinated 70% of adults before UK reaches its target, says head of EU taskforce
The UK will be reliant on the EU to complete its vaccine rollout and a little recognition of that would not go amiss, the European commissioner leading Brussels’ vaccine taskforce has said – adding that Europe could have fully vaccinated 70% of adults before the UK reaches its own target of one dose for all over-18s by the end of July.

Thierry Breton also said AstraZeneca had agreed that almost all the Covid vaccine doses made in the Netherlands over which the UK has made a claim will stay in the EU.

The first phase of the UK’s vaccination rollout was “hugely impressive”, Breton said, but Britain was “starting to realise that one dose is not enough, that you also need second doses – and that to a large extent it will be dependent on Europe” for them.

“I won’t suggest to the prime minister that he says thank you – that’s not my role,” he said. “But maybe a little signal to the women and men now working night and day in 53 factories across Europe to help supply the UK would be welcome.”

He said the UK had chosen a company to produce the Oxford vaccine that “had the advantage of being based in Britain, but no real experience in vaccine production … And we’re seeing today what that means.”

Breton said Europe was expecting 360m doses from five manufacturers in the second quarter, with European factories on course to be producing 200m shots a month by September for an overall capacity of 2bn-3bn by the end of the year.

The EU would “not let Britain down”, he said. “My sole objective is to make sure Europe produces the vaccines, for us and our friends, because this is a pandemic. But I think people will understand that we will put ourselves first, then our friends – albeit with a very short space of time between the two.”

Breton said Pascal Soriot, the chief executive of AstraZeneca, had confirmed to him that all but 1.2m-1.5m doses at a Dutch plant owned by the Anglo-Swedish company’s Halix subcontractor would be delivered to EU member states.

Breton said the plant’s management had told him – contrary to some press reports – that it had received no UK government funding. Britain had nonetheless claimed a contractual right to the 7.5m doses a month it produced, later suggesting a 50/50 split.

Breton said AstraZeneca had conceded that all but one batch of the plant’s vaccines would stay in the EU. “I organised a three-way video teleconference between the CEOs of Halix and AstraZeneca, and finally the CEO of AstraZeneca recognised that all the production of Halix was planned to support the EU delivery,” he said.

The stockpile at the plant in Leiden had been seen in Whitehall as key in making up a shortfall in UK production and deliveries from India, where the government has in effect imposed an export ban on AstraZeneca doses made by the Serum Institute.

Breton said the European commission and AstraZeneca had signed a “best efforts” contract relying on five factories, including two in the UK, “a few days” before Britain had signed its deal, which he said he had not seen.

“I’m told the British health minister has said the UK has an ‘exclusivity contract’,” he said. “But I cannot imagine the company took the legal risk of signing an ‘exclusivity’ contract just after signing a ‘best efforts’ contract. That seems to me very dangerous legally. I cannot think it is the reality.”

Breton said he was confident AstraZeneca would meet its commitment to supply 70m doses to the EU in the second quarter, because the output of the Halix plant and the company’s Seneffe factory in Belgium “pretty much matches” the total promised.

But he noted the company had signed up to deliver 180m doses in the second quarter, and said the company had managed to supply only 30m of a contracted 120m doses in the first quarter. All the EU’s other suppliers had produced more than forecast, he said.

Britain, the EU and AstraZeneca have been in fraught talks since it emerged last month that 21m shots produced in the EU had been exported to the UK, with none coming the other way. Brussels has since toughened its export restrictions to ensure vaccine-producing countries show “reciprocity” by sharing their output.

Breton said the “extremely rapid” increase in European production capacity should allow the EU27 to compensate for first-quarter shortfalls. Increased supplies have allowed several members states to set new daily vaccination records this week, including Germany (650,000), Spain (453,000) and France (437,000).

The bloc is on course to meet its target of fully inoculating 70% of its adult population by mid-July, he said, “with vaccines that will all have been produced in Europe”. He said that after a slow start, “like the fable of the tortoise and the hare”, it looked as if the European campaign was accelerating as the British rollout was starting to flag.

“The British policy of prioritising first doses was completely understandable, but it means it now has to find second doses, and in a hurry,” he said. “I don’t want to make anyone anxious, we will of course do all we can to meet their needs, but we also have certain constraints in Europe.”

Breton said politics were “harmful” to all vaccination campaigns. He said he was confident that in terms of production capacity, the EU would meet its 70% target, allowing it “an almost normal tourist season”, and that the UK should be able to meet its objective of administering a single dose to the whole of its adult population by the end of July.

“I think we may have a few weeks’ lead,” he said. “But it’s got nothing to do with Brexit, nothing to do with politics. Our objective is to meet our target, and to help our friends meet theirs. That is in everyone’s interest. Once again, I’m not asking for thanks. I’m just asking for people to say things as they are.”
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
Princesses Beatrice and Eugenie Temporarily Leave the UK Amid Their Parents’ Royal Fallout
UK Weighs Early End to Oil and Gas Windfall Tax as Reeves Seeks Investment Commitments
UK Retail Inflation Slows as Shop Prices Fall for First Time Since Spring
Next Raises Full-Year Profit Guidance After Strong Third-Quarter Performance
Reform UK’s Lee Anderson Admits to 'Gaming' Benefits System While Advocating Crackdown
United States and South Korea Conclude Major Trade Accord Worth $350 Billion
Hurricane Melissa Strikes Cuba After Devastating Jamaica With Record Winds
Vice President Vance to Headline Turning Point USA Campus Event at Ole Miss
U.S. Targets Maritime Narco-Routes While Border Pressure to Mexico Remains Limited
Bill Gates at 70: “I Have a Real Fear of Artificial Intelligence – and Also Regret”
Elon Musk Unveils Grokipedia: An AI-Driven Alternative to Wikipedia
Saudi Arabia Unveils Vision for First-Ever "Sky Stadium" Suspended Over Desert Floor
Amazon Announces 14 000 Corporate Job Cuts as AI Investment Accelerates
UK Shop Prices Fall for First Time Since March, Food Leads the Decline
London Stock Exchange Group ADR (LNSTY) Earns Zacks Rank #1 Upgrade on Rising Earnings Outlook
Soap legend Tony Adams, long-time star of Crossroads, dies at 84
Rachel Reeves Signals Tax Increases Ahead of November Budget Amid £20-50 Billion Fiscal Gap
NatWest Past Gains of 314% Spotlight Opportunity — But Some Key Risks Remain
UK Launches ‘Golden Age’ of Nuclear with £38 Billion Sizewell C Approval
UK Announces £1.08 Billion Budget for Offshore Wind Auction to Boost 2030 Capacity
UK Seeks Steel Alliance with EU and US to Counter China’s Over-Capacity
UK Struggles to Balance China as Both Strategic Threat and Valued Trading Partner
Argentina’s Markets Surge as Milei’s Party Secures Major Win
British Journalist Sami Hamdi Detained by U.S. Authorities After Visa Revocation Amid Israel-Gaza Commentary
King Charles Unveils UK’s First LGBT+ Armed Forces Memorial at National Memorial Arboretum
At ninety-two and re-elected: Paul Biya secures eighth term in Cameroon amid unrest
Racist Incidents Against UK Nurses Surge by 55%
UK Chancellor Rachel Reeves Cites Shared Concerns With Trump Administration as Foundation for Early US-UK Trade Deal
Essentra plc: A Closer Look at a UK ‘Penny Stock’ Opportunity Amid Market Weakness
U.S. and China Near Deal to Avert Rare-Earth Export Controls Ahead of Trump-Xi Summit
Justin time: Justin Herbert Shields Madison Beer with Impressive Reflex at Lakers Game
Russia’s President Putin Declares Burevestnik Nuclear Cruise Missile Ready for Deployment
Giuffre’s Memoir Alleges Maxwell Claimed Sexual Act with Clooney
House Republicans Move to Strip NYC Mayoral Front-Runner Zohran Mamdani of U.S. Citizenship
Record-High Spoiled Ballots Signal Voter Discontent in Ireland’s 2025 Presidential Election
Philippines’ Taal Volcano Erupts Overnight with 2.4 km Ash Plume
Albania’s Virtual AI 'Minister' Diella Set to 'Birth' Eighty-Three Digital Assistants for MPs
Tesla Unveils Vision for Optimus V3 as ‘Biggest Product of All Time’, Including Surgical Capabilities
Francis Ford Coppola Auctions Luxury Watches After Self-Financed Film Flop
Convicted Sex Offender Mistakenly Freed by UK Prison Service Arrested in London
United States and China Begin Constructive Trade Negotiations Ahead of Trump–Xi Summit
U.S. Treasury Sanctions Colombia’s President Gustavo Petro over Drug-Trafficking Allegations
Miss USA Crowns Nebraska’s Audrey Eckert Amid Leadership Overhaul
‘I Am Not Done’: Kamala Harris Signals Possible 2028 White House Run
NBA Faces Integrity Crisis After Mass Arrests in Gambling Scandal
Swift Heist at the Louvre Sees Eight French Crown Jewels Stolen in Under Seven Minutes
U.S. Halts Trade Talks with Canada After Ontario Ad Using Reagan Voice Triggers Diplomatic Fallout
Microsoft AI CEO: ‘We’re making an AI that you can trust your kids to use’ — but can Microsoft rebuild its own trust before fixing the industry’s?
×